Global and Europe Oral hypoglycemic agents and insulin analogues Market - Analysis and Outlook to 2022

July 2017 | 133 pages | ID: GDFBF262A06EN
EU Research

Abstracts

This report presents a comprehensive overview of the Oral hypoglycemic agents and insulin analogues market in Europe, which shares the history data information from 2012 to 2016, and forecast from 2017 to 2022.
This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Oral hypoglycemic agents and insulin analogues industry.

This report focuses Global and Europe market, including details as following:

Key Players

• AARTI DRUGS LIMITED IN 400 022 Mumbai
• Abhilash Chemicals Private Limited IN 652301 Madurai
• ACTAVIS GROUP PTC EHF IS 220 Hafnarfjordur
• Auro Laboratories Limited IN 400030 Mumbai
• AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad
• BAL PHARMA LIMITED IN 560 052 Bangalore
• BAYER AG DE 51373 Leverkusen
• BIOCON LIMITED IN 560 100 Bangalore
• BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West
• Boehringer Ingelheim Pharma GmbH & Co. KG DE 55216 Ingelheim Am Rhein
• Chongqing Carelife Pharmaceutical Co. Ltd. CN 401 254 Chongqing
• CHROMO LABORATORIES INDIA PRIVATE LIMITED IN 502 307 Pashamylaram
• CIPLA LIMITED IN 400 013 Mumbai
• CKD BIO CORPORATION KR 15604 Ansan-si
• DISHMAN CARBOGEN AMCIS LIMITED IN 380 009 Ahmedabad
• DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad
• EDMOND PHARMA S.R.L. IT 20037 Paderno Dugnano
• ELIXIR PHARMA IN 382 330 Ahmedabad
• EXEMED PHARMACEUTICALS IN 391 440 Vadodara
• GLENMARK PHARMACEUTICALS LIMITED IN 400 099 Mumbai
• GRANULES INDIA LIMITED IN 500 081 Hyderabad
• HARMAN FINOCHEM LIMITED IN 400 098 Mumbai
• Hebei Huarong Pharmaceutical Co Ltd CN 050 041 Shijiazhuang
• HETERO LABS LIMITED IN 500 018 Hyderabad
• HUADONG MEDICINE CO., LTD. CN 310 011 Hangzhou
• INDOCO REMEDIES LIMITED IN 400 098 Mumbai
• INIST ST CO., LTD. KR 369-901 Eumseong-gun
• IOL CHEMICALS AND PHARMACEUTICALS LTD IN 148 101 Fatehgarh Channa Village
• IPCA Laboratories Limited IN 400 067 Mumbai
• JUBILANT GENERICS LIMITED IN 571 302 Nanjangud

Key Regions

• North America
• United States
• Canada
• Latin America
• Mexico
• Brazil
• Argentina
• Others
• Europe
• Germany
• United Kingdom
• France
• Italy
• Spain
• Russia
• Netherland
• Others
• Asia & Pacific
• China
• Japan
• India
• Korea
• Australia
• Southeast Asia
• Indonesia
• Thailand
• Philippines
• Vietnam
• Singapore
• Malaysia
• Others
• Africa & Middle East
• South Africa
• Egypt
• Turkey
• Saudi Arabia
• Iran
• Others

Key Product Type
Oral hypoglycemic agents and insulin analogues Market, by Insulin sensitizing agents

• Metformin
• Buformin
• Phenformin
• Pioglitazone
• Rosiglitazone
• Troglitazone
• Aleglitazar
• Muraglitazar
• Tesaglitazar

Oral hypoglycemic agents and insulin analogues Market, by Secretagogue

• Acetohexamide
• Carbutamide
• Chlorpropamide
• Metahexamide
• Tolazamide
• Tolbutamide
• Glibenclamide
• Glibornuride
• Glipizide
• Gliquidone
• Glisoxepide
• Glyclopyramide
• Glimepiride
• Gliclazide
• Nateglinide
• Repaglinide
• Mitiglinide
• Exenatide
• Liraglutide
• Lixisenatide
• Linagliptin
• Saxagliptin
• Sitagliptin
• Vildagliptin

Oral hypoglycemic agents and insulin analogues Market, by Insulin class

• Insulin Lispro
• Insulin aspart
• Glulisine
• insulin
• insulin glargine
• insulin detemir
• neutral protamine Hagedorn insulin

Oral hypoglycemic agents and insulin analogues Market, by Others

• Acarbose
• Miglitol
• Voglibose
• Pramlintide
• Benfluorex
• Tolrestat

Key Applications

• Department of endocrinology
• Diabetes division
• Pharmacy
• Hospital

Contents

Global and Europe Oral hypoglycemic agents and insulin analogues Market - Analysis and Outlook to 2022

1 MARKET OUTLINE

1.1 Research Methodology
  1.1.1 Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
  1.1.2 Data Source
Secondary Sources
Primary Sources
  1.1.3 Disclaimer
1.2 Regulatory Factors
1.3 End-User Analysis
1.4 Strategic Benchmarking
1.5 Industry Chain and Supply Chain
  1.5.1 Oral hypoglycemic agents and insulin analogues Industry Chain Structure
    1.5.1.1 R&D
    1.5.1.2 Raw Materials (Components)
    1.5.1.3 Manufacturing Plants
    1.5.1.4 Regional Trading (Import Export and Local Sales)
    1.5.1.5 Online Sales Channel
    1.5.1.6 Offline Channel
    1.5.1.7 End Users
  1.5.2 Oral hypoglycemic agents and insulin analogues Manufacturing
    1.5.2.1 Key Components
    1.5.2.2 Assembly Manufacturing
  1.5.3 Consumer Preference
  1.5.4 Behavioral Habits
  1.5.5 Marketing Environment
1.6 SWOT Analysis
1.7 Feasibility Analysis
1.8 Development Trend and Research Conclusion
  1.8.1 Development Trend
  1.8.2 Research Conclusion

2 GLOBAL ORAL HYPOGLYCEMIC AGENTS AND INSULIN ANALOGUES PRODUCT OVERVIEW

2.1 Global Oral hypoglycemic agents and insulin analogues Market Sales Volume Revenue and Price 2012-2017
2.2 Oral hypoglycemic agents and insulin analogues, by Insulin sensitizing agents 2012-2017
  2.2.1 Global Oral hypoglycemic agents and insulin analogues Sales Market Share by Insulin sensitizing agents 2012-2017
  2.2.2 Global Oral hypoglycemic agents and insulin analogues Revenue Market Share by Insulin sensitizing agents 2012-2017
  2.2.3 Global Oral hypoglycemic agents and insulin analogues Price by Insulin sensitizing agents 2012-2017
  2.2.4 Metformin
  2.2.5 Buformin
  2.2.6 Phenformin
  2.2.7 Pioglitazone
  2.2.8 Rosiglitazone
  1.2.8 Tolazamide
  1.2.9 Troglitazone
  1.2.10 Aleglitazar
  1.2.11 Muraglitazar
  1.2.12 Tesaglitazar
2.3 Oral hypoglycemic agents and insulin analogues, by Secretagogue 2012-2017
  2.3.1 Global Oral hypoglycemic agents and insulin analogues Sales Market Share by Secretagogue 2012-2017
  2.3.2 Global Oral hypoglycemic agents and insulin analogues Revenue Market Share by Secretagogue 2012-2017
  2.3.3 Global Oral hypoglycemic agents and insulin analogues Price by Secretagogue 2012-2017
  2.3.4 Acetohexamide
  2.3.5 Carbutamide
  2.3.6 Chlorpropamide
  2.3.7 Metahexamide
  2.3.8 Tolazamide
  1.3.9 Tolbutamide
  1.3.10 Glibenclamide
  1.3.11 Glibornuride
  1.3.12 Glipizide
  1.3.13 Gliquidone
  1.3.14 Glisoxepide
  1.3.15 Glyclopyramide
  1.3.16 Glimepiride
  1.3.17 Gliclazide
  1.3.18 Nateglinide
  1.3.19 Repaglinide
  1.3.20 Mitiglinide
  1.3.21 Exenatide
  1.3.22 Liraglutide
  1.3.23 Lixisenatide
  1.3.24 Linagliptin
  1.3.25 Saxagliptin
  1.3.26 Sitagliptin
  1.2.37 Vildagliptin
2.4 Oral hypoglycemic agents and insulin analogues, by Insulin class 2012-2017
  2.4.1 Global Oral hypoglycemic agents and insulin analogues Sales Market Share by Insulin class 2012-2017
  2.4.2 Global Oral hypoglycemic agents and insulin analogues Revenue Market Share by Insulin class 2012-2017
  2.4.3 Global Oral hypoglycemic agents and insulin analogues Price by Insulin class 2012-2017
  2.4.4 Insulin Lispro
  2.4.5 Insulin aspart
  2.4.6 Glulisine
  2.4.7 insulin
  2.4.8 insulin glargine
  1.4.9 neutral protamine Hagedorn insulin
2.5 Oral hypoglycemic agents and insulin analogues, by Others 2012-2017
  2.5.1 Global Oral hypoglycemic agents and insulin analogues Sales Market Share by Others 2012-2017
  2.5.2 Global Oral hypoglycemic agents and insulin analogues Revenue Market Share by Others 2012-2017
  2.5.3 Global Oral hypoglycemic agents and insulin analogues Price by Others 2012-2017
  2.5.4 Acarbose
  2.5.5 Miglitol
  2.5.6 Voglibose
  2.5.7 Pramlintide
  2.5.8 Benfluorex
  1.5.9 Tolrestat

3 EUROPE ORAL HYPOGLYCEMIC AGENTS AND INSULIN ANALOGUES PRODUCT OVERVIEW

3.1 Europe Oral hypoglycemic agents and insulin analogues Market Sales Volume Revenue and Price 2012-2017
3.2 Oral hypoglycemic agents and insulin analogues, by Insulin sensitizing agents 2012-2017
  3.2.1 Europe Oral hypoglycemic agents and insulin analogues Sales Market Share by Insulin sensitizing agents 2012-2017
  3.2.2 Europe Oral hypoglycemic agents and insulin analogues Revenue Market Share by Insulin sensitizing agents 2012-2017
  3.2.3 Europe Oral hypoglycemic agents and insulin analogues Price by Insulin sensitizing agents 2012-2017
  3.2.4 Metformin
  3.2.5 Buformin
  3.2.6 Phenformin
  3.2.7 Pioglitazone
  3.2.8 Rosiglitazone
  1.2.8 Tolazamide
  1.2.9 Troglitazone
  1.2.10 Aleglitazar
  1.2.11 Muraglitazar
  1.2.12 Tesaglitazar
3.3 Oral hypoglycemic agents and insulin analogues, by Secretagogue 2012-2017
  3.3.1 Europe Oral hypoglycemic agents and insulin analogues Sales Market Share by Secretagogue 2012-2017
  3.3.2 Europe Oral hypoglycemic agents and insulin analogues Revenue Market Share by Secretagogue 2012-2017
  3.3.3 Europe Oral hypoglycemic agents and insulin analogues Price by Secretagogue 2012-2017
  3.3.4 Acetohexamide
  3.3.5 Carbutamide
  3.3.6 Chlorpropamide
  3.3.7 Metahexamide
  3.3.8 Tolazamide
  1.3.9 Tolbutamide
  1.3.10 Glibenclamide
  1.3.11 Glibornuride
  1.3.12 Glipizide
  1.3.13 Gliquidone
  1.3.14 Glisoxepide
  1.3.15 Glyclopyramide
  1.3.16 Glimepiride
  1.3.17 Gliclazide
  1.3.18 Nateglinide
  1.3.19 Repaglinide
  1.3.20 Mitiglinide
  1.3.21 Exenatide
  1.3.22 Liraglutide
  1.3.23 Lixisenatide
  1.3.24 Linagliptin
  1.3.25 Saxagliptin
  1.3.26 Sitagliptin
  1.2.37 Vildagliptin
3.4 Oral hypoglycemic agents and insulin analogues, by Insulin class 2012-2017
  3.4.1 Europe Oral hypoglycemic agents and insulin analogues Sales Market Share by Insulin class 2012-2017
  3.4.2 Europe Oral hypoglycemic agents and insulin analogues Revenue Market Share by Insulin class 2012-2017
  3.4.3 Europe Oral hypoglycemic agents and insulin analogues Price by Insulin class 2012-2017
  3.4.4 Insulin Lispro
  3.4.5 Insulin aspart
  3.4.6 Glulisine
  3.4.7 insulin
  3.4.8 insulin glargine
  1.4.9 neutral protamine Hagedorn insulin
3.5 Oral hypoglycemic agents and insulin analogues, by Others 2012-2017
  3.5.1 Europe Oral hypoglycemic agents and insulin analogues Sales Market Share by Others 2012-2017
  3.5.2 Europe Oral hypoglycemic agents and insulin analogues Revenue Market Share by Others 2012-2017
  3.5.3 Europe Oral hypoglycemic agents and insulin analogues Price by Others 2012-2017
  3.5.4 Acarbose
  3.5.5 Miglitol
  3.5.6 Voglibose
  3.5.7 Pramlintide
  3.5.8 Benfluorex
  1.5.9 Tolrestat

4 ORAL HYPOGLYCEMIC AGENTS AND INSULIN ANALOGUES TOP COMPANIES PROFILE

4.1 AARTI DRUGS LIMITED IN 400 022 Mumbai
  4.1.1 AARTI DRUGS LIMITED IN 400 022 Mumbai Company Details and Competitors
  4.1.2 AARTI DRUGS LIMITED IN 400 022 Mumbai Key Oral hypoglycemic agents and insulin analogues Models and Performance
  4.1.3 AARTI DRUGS LIMITED IN 400 022 Mumbai Oral hypoglycemic agents and insulin analogues Business SWOT Analysis and Forecast
  4.1.4 AARTI DRUGS LIMITED IN 400 022 Mumbai Oral hypoglycemic agents and insulin analogues Sales Volume Revenue Price Cost and Gross Margin
4.2 Abhilash Chemicals Private Limited IN 652301 Madurai
  4.2.1 Abhilash Chemicals Private Limited IN 652301 Madurai Company Details and Competitors
  4.2.2 Abhilash Chemicals Private Limited IN 652301 Madurai Key Oral hypoglycemic agents and insulin analogues Models and Performance
  4.2.3 Abhilash Chemicals Private Limited IN 652301 Madurai Oral hypoglycemic agents and insulin analogues Business SWOT Analysis and Forecast
  4.2.4 Abhilash Chemicals Private Limited IN 652301 Madurai Oral hypoglycemic agents and insulin analogues Sales Volume Revenue Price Cost and Gross Margin
4.3 ACTAVIS GROUP PTC EHF IS 220 Hafnarfjordur
  4.3.1 ACTAVIS GROUP PTC EHF IS 220 Hafnarfjordur Company Details and Competitors
  4.3.2 ACTAVIS GROUP PTC EHF IS 220 Hafnarfjordur Key Oral hypoglycemic agents and insulin analogues Models and Performance
  4.3.3 ACTAVIS GROUP PTC EHF IS 220 Hafnarfjordur Oral hypoglycemic agents and insulin analogues Business SWOT Analysis and Forecast
  4.3.4 ACTAVIS GROUP PTC EHF IS 220 Hafnarfjordur Oral hypoglycemic agents and insulin analogues Sales Volume Revenue Price Cost and Gross Margin
4.4 Auro Laboratories Limited IN 400030 Mumbai
  4.4.1 Auro Laboratories Limited IN 400030 Mumbai Company Details and Competitors
  4.4.2 Auro Laboratories Limited IN 400030 Mumbai Key Oral hypoglycemic agents and insulin analogues Models and Performance
  4.4.3 Auro Laboratories Limited IN 400030 Mumbai Oral hypoglycemic agents and insulin analogues Business SWOT Analysis and Forecast
  4.4.4 Auro Laboratories Limited IN 400030 Mumbai Oral hypoglycemic agents and insulin analogues Sales Volume Revenue Price Cost and Gross Margin
4.5 AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad
  4.5.1 AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Company Details and Competitors
  4.5.2 AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Key Oral hypoglycemic agents and insulin analogues Models and Performance
  4.5.3 AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Oral hypoglycemic agents and insulin analogues Business SWOT Analysis and Forecast
  4.5.4 AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Oral hypoglycemic agents and insulin analogues Sales Volume Revenue Price Cost and Gross Margin
4.6 BAL PHARMA LIMITED IN 560 052 Bangalore
  4.6.1 BAL PHARMA LIMITED IN 560 052 Bangalore Company Details and Competitors
  4.6.2 BAL PHARMA LIMITED IN 560 052 Bangalore Key Oral hypoglycemic agents and insulin analogues Models and Performance
  4.6.3 BAL PHARMA LIMITED IN 560 052 Bangalore Oral hypoglycemic agents and insulin analogues Business SWOT Analysis and Forecast
  4.6.4 BAL PHARMA LIMITED IN 560 052 Bangalore Oral hypoglycemic agents and insulin analogues Sales Volume Revenue Price Cost and Gross Margin
4.7 BAYER AG DE 51373 Leverkusen
  4.7.1 BAYER AG DE 51373 Leverkusen Company Details and Competitors
  4.7.2 BAYER AG DE 51373 Leverkusen Key Oral hypoglycemic agents and insulin analogues Models and Performance
  4.7.3 BAYER AG DE 51373 Leverkusen Oral hypoglycemic agents and insulin analogues Business SWOT Analysis and Forecast
  4.7.4 BAYER AG DE 51373 Leverkusen Oral hypoglycemic agents and insulin analogues Sales Volume Revenue Price Cost and Gross Margin
4.8 BIOCON LIMITED IN 560 100 Bangalore
  4.8.1 BIOCON LIMITED IN 560 100 Bangalore Company Details and Competitors
  4.8.2 BIOCON LIMITED IN 560 100 Bangalore Key Oral hypoglycemic agents and insulin analogues Models and Performance
  4.8.3 BIOCON LIMITED IN 560 100 Bangalore Oral hypoglycemic agents and insulin analogues Business SWOT Analysis and Forecast
  4.8.4 BIOCON LIMITED IN 560 100 Bangalore Oral hypoglycemic agents and insulin analogues Sales Volume Revenue Price Cost and Gross Margin
4.9 BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West
  4.9.1 BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Company Details and Competitors
  4.9.2 BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Key Oral hypoglycemic agents and insulin analogues Models and Performance
  4.9.3 BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Oral hypoglycemic agents and insulin analogues Business SWOT Analysis and Forecast
  4.9.4 BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Oral hypoglycemic agents and insulin analogues Sales Volume Revenue Price Cost and Gross Margin
4.10 Boehringer Ingelheim Pharma GmbH & Co. KG DE 55216 Ingelheim Am Rhein
  4.10.1 Boehringer Ingelheim Pharma GmbH & Co. KG DE 55216 Ingelheim Am Rhein Company Details and Competitors
  4.10.2 Boehringer Ingelheim Pharma GmbH & Co. KG DE 55216 Ingelheim Am Rhein Key Oral hypoglycemic agents and insulin analogues Models and Performance
  4.10.3 Boehringer Ingelheim Pharma GmbH & Co. KG DE 55216 Ingelheim Am Rhein Oral hypoglycemic agents and insulin analogues Business SWOT Analysis and Forecast
  4.10.4 Boehringer Ingelheim Pharma GmbH & Co. KG DE 55216 Ingelheim Am Rhein Oral hypoglycemic agents and insulin analogues Sales Volume Revenue Price Cost and Gross Margin
4.11 Chongqing Carelife Pharmaceutical Co. Ltd. CN 401 254 Chongqing
4.12 CHROMO LABORATORIES INDIA PRIVATE LIMITED IN 502 307 Pashamylaram
4.13 CIPLA LIMITED IN 400 013 Mumbai
4.14 CKD BIO CORPORATION KR 15604 Ansan-si
4.15 DISHMAN CARBOGEN AMCIS LIMITED IN 380 009 Ahmedabad
4.16 DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad
4.17 EDMOND PHARMA S.R.L. IT 20037 Paderno Dugnano
4.18 ELIXIR PHARMA IN 382 330 Ahmedabad
4.19 EXEMED PHARMACEUTICALS IN 391 440 Vadodara
4.20 GLENMARK PHARMACEUTICALS LIMITED IN 400 099 Mumbai
4.21 GRANULES INDIA LIMITED IN 500 081 Hyderabad
4.22 HARMAN FINOCHEM LIMITED IN 400 098 Mumbai
4.23 Hebei Huarong Pharmaceutical Co Ltd CN 050 041 Shijiazhuang
4.24 HETERO LABS LIMITED IN 500 018 Hyderabad
4.25 HUADONG MEDICINE CO., LTD. CN 310 011 Hangzhou
4.26 INDOCO REMEDIES LIMITED IN 400 098 Mumbai
4.27 INIST ST CO., LTD. KR 369-901 Eumseong-gun
4.28 IOL CHEMICALS AND PHARMACEUTICALS LTD IN 148 101 Fatehgarh Channa Village
4.29 IPCA Laboratories Limited IN 400 067 Mumbai
4.30 JUBILANT GENERICS LIMITED IN 571 302 Nanjangud

5 ORAL HYPOGLYCEMIC AGENTS AND INSULIN ANALOGUES BY REGIONS 2012-2017

5.1 Global Oral hypoglycemic agents and insulin analogues Sales Market Share by Regions 2012-2017
5.2 Global Oral hypoglycemic agents and insulin analogues Revenue Market Share by Regions 2012-2017
5.3 Global Oral hypoglycemic agents and insulin analogues Price by Regions 2012-2017
5.4 North America
  5.4.1 United States
  5.4.2 Canada
5.5 Latin America
  5.5.1 Mexico
  5.5.2 Brazil
  5.5.3 Argentina
  5.5.4 Others in Latin America
5.6 Europe
  5.6.1 Germany
  5.6.2 United Kingdom
  5.6.3 France
  5.6.4 Italy
  5.6.5 Spain
  5.6.6 Russia
  5.6.7 Netherland
  5.6.8 Others in Europe
5.7 Asia & Pacific
  5.7.1 China
  5.7.2 Japan
  5.7.3 India
  5.7.4 Korea
  5.7.5 Australia
  5.7.6 Southeast Asia
    5.7.6.1 Indonesia
    5.7.6.2 Thailand
    5.7.6.3 Philippines
    5.7.6.4 Vietnam
    5.7.6.5 Singapore
    5.7.6.6 Malaysia
    5.7.6.7 Others in Southeast Asia
5.8 Africa & Middle East
  5.8.1 South Africa
  5.8.2 Egypt
  5.8.3 Turkey
  5.8.4 Saudi Arabia
  5.8.5 Iran
  5.8.6 Others in Africa & Middle East

6 GLOBALORAL HYPOGLYCEMIC AGENTS AND INSULIN ANALOGUES BY PLAYERS 2012-2017

6.1 Global Oral hypoglycemic agents and insulin analogues Sales Volume Market Share by Brands 2012-2017
6.2 Global Oral hypoglycemic agents and insulin analogues Revenue Share by Brands 2012-2017
6.3 Global Top Players Oral hypoglycemic agents and insulin analogues Key Product Model and Market Performance
6.4 Global Top Players Oral hypoglycemic agents and insulin analogues Key Target Consumers and Market Performance

7 EUROPEORAL HYPOGLYCEMIC AGENTS AND INSULIN ANALOGUES BY PLAYERS 2012-2017

7.1 Europe Oral hypoglycemic agents and insulin analogues Sales Volume Market Share by Brands 2012-2017
7.2 Europe Oral hypoglycemic agents and insulin analogues Revenue Share by Brands 2012-2017
7.3 Europe Top Players Oral hypoglycemic agents and insulin analogues Key Product Model and Market Performance
7.4 Europe Top Players Oral hypoglycemic agents and insulin analogues Key Target Consumers and Market Performance

8 GLOBAL ORAL HYPOGLYCEMIC AGENTS AND INSULIN ANALOGUES BY CONSUMER 2012-2017

8.1 Global Oral hypoglycemic agents and insulin analogues Sales Market Share by Consumer 2012-2017
8.2 Department of endocrinology
8.3 Diabetes division
8.4 Pharmacy
8.5 Hospital
8.6 Consuming Habit and Preference

9 EUROPE ORAL HYPOGLYCEMIC AGENTS AND INSULIN ANALOGUES BY CONSUMER 2012-2017

9.1 Europe Oral hypoglycemic agents and insulin analogues Sales Market Share by Consumer 2012-2017
9.2 Department of endocrinology
9.3 Diabetes division
9.4 Pharmacy
9.5 Hospital
9.6 Consuming Habit and Preference

10 GLOBAL ORAL HYPOGLYCEMIC AGENTS AND INSULIN ANALOGUES MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

10.1 Global Oral hypoglycemic agents and insulin analogues Sales (), Revenue (Million USD) Forecast (2017-2022)
10.2 Global Oral hypoglycemic agents and insulin analogues Sales () Forecast by Regions (2017-2022)
10.3 Global Oral hypoglycemic agents and insulin analogues Sales () Forecast by Application (2017-2022)
10.4 Global Oral hypoglycemic agents and insulin analogues Sales () Forecast by Insulin sensitizing agents (2017-2022)
10.5 Global Oral hypoglycemic agents and insulin analogues Sales () Forecast by Secretagogue (2017-2022)
10.6 Global Oral hypoglycemic agents and insulin analogues Sales () Forecast by Insulin class (2017-2022)
10.7 Global Oral hypoglycemic agents and insulin analogues Sales () Forecast by Others (2017-2022)

11 EUROPE ORAL HYPOGLYCEMIC AGENTS AND INSULIN ANALOGUES MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 Europe Oral hypoglycemic agents and insulin analogues Sales (), Revenue (Million USD) Forecast (2017-2022)
11.2 Europe Oral hypoglycemic agents and insulin analogues Sales () Forecast by Regions (2017-2022)
11.3 Europe Oral hypoglycemic agents and insulin analogues Sales () Forecast by Application (2017-2022)
11.4 Europe Oral hypoglycemic agents and insulin analogues Sales () Forecast by Insulin sensitizing agents (2017-2022)
11.5 Europe Oral hypoglycemic agents and insulin analogues Sales () Forecast by Secretagogue (2017-2022)
11.6 Europe Oral hypoglycemic agents and insulin analogues Sales () Forecast by Insulin class (2017-2022)
11.7 Europe Oral hypoglycemic agents and insulin analogues Sales () Forecast by Others (2017-2022)

List Of Tables

LIST OF TABLES AND FIGURES

Table Global Oral hypoglycemic agents and insulin analogues Sales Volume (), Revenue (Million USD) and Price () (2012-2017)
Figure Global Oral hypoglycemic agents and insulin analogues Revenue (Million USD) and Growth Rate (2012-2017)
Figure Global Oral hypoglycemic agents and insulin analogues Sales Volume () and Growth Rate (2012-2017)
Table Global Oral hypoglycemic agents and insulin analogues Sales () by Insulin sensitizing agents (2012-2017)
Table Global Oral hypoglycemic agents and insulin analogues Sales Market Share by Insulin sensitizing agents (2012-2017)
Figure Global Oral hypoglycemic agents and insulin analogues Sales Market Share by Insulin sensitizing agents in 2016
Table Global Oral hypoglycemic agents and insulin analogues Revenue (Million USD) by Insulin sensitizing agents (2012-2017)
Table Global Oral hypoglycemic agents and insulin analogues Revenue Market Share by Insulin sensitizing agents (2012-2017)
Figure Global Oral hypoglycemic agents and insulin analogues Revenue Market Share by Insulin sensitizing agents in 2016
Table Global Oral hypoglycemic agents and insulin analogues Price () by Insulin sensitizing agents (2012-2017)
Table Top Players of Metformin Oral hypoglycemic agents and insulin analogues Products List
Figure Global Metformin Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Buformin Oral hypoglycemic agents and insulin analogues Products List
Figure Global Buformin Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Phenformin Oral hypoglycemic agents and insulin analogues Products List
Figure Global Phenformin Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Pioglitazone Oral hypoglycemic agents and insulin analogues Products List
Figure Global Pioglitazone Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Rosiglitazone Oral hypoglycemic agents and insulin analogues Products List
Figure Global Rosiglitazone Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Global Oral hypoglycemic agents and insulin analogues Sales () by Secretagogue (2012-2017)
Table Global Oral hypoglycemic agents and insulin analogues Sales Market Share by Secretagogue (2012-2017)
Figure Global Oral hypoglycemic agents and insulin analogues Sales Market Share by Secretagogue in 2016
Table Global Oral hypoglycemic agents and insulin analogues Revenue (Million USD) by Secretagogue (2012-2017)
Table Global Oral hypoglycemic agents and insulin analogues Revenue Market Share by Secretagogue (2012-2017)
Figure Global Oral hypoglycemic agents and insulin analogues Revenue Market Share by Secretagogue in 2016
Table Global Oral hypoglycemic agents and insulin analogues Price () by Secretagogue (2012-2017)
Table Top Players of Acetohexamide Oral hypoglycemic agents and insulin analogues Products List
Figure Global Acetohexamide Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Carbutamide Oral hypoglycemic agents and insulin analogues Products List
Figure Global Carbutamide Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Chlorpropamide Oral hypoglycemic agents and insulin analogues Products List
Figure Global Chlorpropamide Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Metahexamide Oral hypoglycemic agents and insulin analogues Products List
Figure Global Metahexamide Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Tolazamide Oral hypoglycemic agents and insulin analogues Products List
Figure Global Tolazamide Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Global Oral hypoglycemic agents and insulin analogues Sales () by Insulin class (2012-2017)
Table Global Oral hypoglycemic agents and insulin analogues Sales Market Share by Insulin class (2012-2017)
Figure Global Oral hypoglycemic agents and insulin analogues Sales Market Share by Insulin class in 2016
Table Global Oral hypoglycemic agents and insulin analogues Revenue (Million USD) by Insulin class (2012-2017)
Table Global Oral hypoglycemic agents and insulin analogues Revenue Market Share by Insulin class (2012-2017)
Figure Global Oral hypoglycemic agents and insulin analogues Revenue Market Share by Insulin class in 2016
Table Global Oral hypoglycemic agents and insulin analogues Price () by Insulin class (2012-2017)
Table Top Players of Insulin Lispro Oral hypoglycemic agents and insulin analogues Products List
Figure Global Insulin Lispro Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Insulin aspart Oral hypoglycemic agents and insulin analogues Products List
Figure Global Insulin aspart Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Glulisine Oral hypoglycemic agents and insulin analogues Products List
Figure Global Glulisine Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of insulin Oral hypoglycemic agents and insulin analogues Products List
Figure Global insulin Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of insulin glargine Oral hypoglycemic agents and insulin analogues Products List
Figure Global insulin glargine Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Global Oral hypoglycemic agents and insulin analogues Sales () by Others (2012-2017)
Table Global Oral hypoglycemic agents and insulin analogues Sales Market Share by Others (2012-2017)
Figure Global Oral hypoglycemic agents and insulin analogues Sales Market Share by Others in 2016
Table Global Oral hypoglycemic agents and insulin analogues Revenue (Million USD) by Others (2012-2017)
Table Global Oral hypoglycemic agents and insulin analogues Revenue Market Share by Others (2012-2017)
Figure Global Oral hypoglycemic agents and insulin analogues Revenue Market Share by Others in 2016
Table Global Oral hypoglycemic agents and insulin analogues Price () by Others (2012-2017)
Table Top Players of Acarbose Oral hypoglycemic agents and insulin analogues Products List
Figure Global Acarbose Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Miglitol Oral hypoglycemic agents and insulin analogues Products List
Figure Global Miglitol Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Voglibose Oral hypoglycemic agents and insulin analogues Products List
Figure Global Voglibose Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Pramlintide Oral hypoglycemic agents and insulin analogues Products List
Figure Global Pramlintide Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Benfluorex Oral hypoglycemic agents and insulin analogues Products List
Figure Global Benfluorex Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Global Oral hypoglycemic agents and insulin analogues Sales () by (2012-2017)
Table Global Oral hypoglycemic agents and insulin analogues Sales Market Share by (2012-2017)
Figure Global Oral hypoglycemic agents and insulin analogues Sales Market Share by in 2016
Table Global Oral hypoglycemic agents and insulin analogues Revenue (Million USD) by (2012-2017)
Table Global Oral hypoglycemic agents and insulin analogues Revenue Market Share by (2012-2017)
Figure Global Oral hypoglycemic agents and insulin analogues Revenue Market Share by in 2016
Table Global Oral hypoglycemic agents and insulin analogues Price () by (2012-2017)
Table Europe Oral hypoglycemic agents and insulin analogues Sales Volume (), Revenue (Million USD) and Price () (2012-2017)
Figure Europe Oral hypoglycemic agents and insulin analogues Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Oral hypoglycemic agents and insulin analogues Sales Volume () and Growth Rate (2012-2017)
Table Europe Oral hypoglycemic agents and insulin analogues Sales () by Insulin sensitizing agents (2012-2017)
Table Europe Oral hypoglycemic agents and insulin analogues Sales Market Share by Insulin sensitizing agents (2012-2017)
Figure Europe Oral hypoglycemic agents and insulin analogues Sales Market Share by Insulin sensitizing agents in 2016
Table Europe Oral hypoglycemic agents and insulin analogues Revenue (Million USD) by Insulin sensitizing agents (2012-2017)
Table Europe Oral hypoglycemic agents and insulin analogues Revenue Market Share by Insulin sensitizing agents (2012-2017)
Figure Europe Oral hypoglycemic agents and insulin analogues Revenue Market Share by Insulin sensitizing agents in 2016
Table Europe Oral hypoglycemic agents and insulin analogues Price () by Insulin sensitizing agents (2012-2017)
Table Top Players of Metformin Oral hypoglycemic agents and insulin analogues Products List
Figure Europe Metformin Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Buformin Oral hypoglycemic agents and insulin analogues Products List
Figure Europe Buformin Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Phenformin Oral hypoglycemic agents and insulin analogues Products List
Figure Europe Phenformin Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Pioglitazone Oral hypoglycemic agents and insulin analogues Products List
Figure Europe Pioglitazone Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Rosiglitazone Oral hypoglycemic agents and insulin analogues Products List
Figure Europe Rosiglitazone Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Europe Oral hypoglycemic agents and insulin analogues Sales () by Secretagogue (2012-2017)
Table Europe Oral hypoglycemic agents and insulin analogues Sales Market Share by Secretagogue (2012-2017)
Figure Europe Oral hypoglycemic agents and insulin analogues Sales Market Share by Secretagogue in 2016
Table Europe Oral hypoglycemic agents and insulin analogues Revenue (Million USD) by Secretagogue (2012-2017)
Table Europe Oral hypoglycemic agents and insulin analogues Revenue Market Share by Secretagogue (2012-2017)
Figure Europe Oral hypoglycemic agents and insulin analogues Revenue Market Share by Secretagogue in 2016
Table Europe Oral hypoglycemic agents and insulin analogues Price () by Secretagogue (2012-2017)
Table Top Players of Acetohexamide Oral hypoglycemic agents and insulin analogues Products List
Figure Europe Acetohexamide Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Carbutamide Oral hypoglycemic agents and insulin analogues Products List
Figure Europe Carbutamide Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Chlorpropamide Oral hypoglycemic agents and insulin analogues Products List
Figure Europe Chlorpropamide Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Metahexamide Oral hypoglycemic agents and insulin analogues Products List
Figure Europe Metahexamide Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Tolazamide Oral hypoglycemic agents and insulin analogues Products List
Figure Europe Tolazamide Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Europe Oral hypoglycemic agents and insulin analogues Sales () by Insulin class (2012-2017)
Table Europe Oral hypoglycemic agents and insulin analogues Sales Market Share by Insulin class (2012-2017)
Figure Europe Oral hypoglycemic agents and insulin analogues Sales Market Share by Insulin class in 2016
Table Europe Oral hypoglycemic agents and insulin analogues Revenue (Million USD) by Insulin class (2012-2017)
Table Europe Oral hypoglycemic agents and insulin analogues Revenue Market Share by Insulin class (2012-2017)
Figure Europe Oral hypoglycemic agents and insulin analogues Revenue Market Share by Insulin class in 2016
Table Europe Oral hypoglycemic agents and insulin analogues Price () by Insulin class (2012-2017)
Table Top Players of Insulin Lispro Oral hypoglycemic agents and insulin analogues Products List
Figure Europe Insulin Lispro Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Insulin aspart Oral hypoglycemic agents and insulin analogues Products List
Figure Europe Insulin aspart Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Glulisine Oral hypoglycemic agents and insulin analogues Products List
Figure Europe Glulisine Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of insulin Oral hypoglycemic agents and insulin analogues Products List
Figure Europe insulin Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of insulin glargine Oral hypoglycemic agents and insulin analogues Products List
Figure Europe insulin glargine Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Europe Oral hypoglycemic agents and insulin analogues Sales () by Others (2012-2017)
Table Europe Oral hypoglycemic agents and insulin analogues Sales Market Share by Others (2012-2017)
Figure Europe Oral hypoglycemic agents and insulin analogues Sales Market Share by Others in 2016
Table Europe Oral hypoglycemic agents and insulin analogues Revenue (Million USD) by Others (2012-2017)
Table Europe Oral hypoglycemic agents and insulin analogues Revenue Market Share by Others (2012-2017)
Figure Europe Oral hypoglycemic agents and insulin analogues Revenue Market Share by Others in 2016
Table Europe Oral hypoglycemic agents and insulin analogues Price () by Others (2012-2017)
Table Top Players of Acarbose Oral hypoglycemic agents and insulin analogues Products List
Figure Europe Acarbose Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Miglitol Oral hypoglycemic agents and insulin analogues Products List
Figure Europe Miglitol Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Voglibose Oral hypoglycemic agents and insulin analogues Products List
Figure Europe Voglibose Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Pramlintide Oral hypoglycemic agents and insulin analogues Products List
Figure Europe Pramlintide Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Top Players of Benfluorex Oral hypoglycemic agents and insulin analogues Products List
Figure Europe Benfluorex Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Europe Oral hypoglycemic agents and insulin analogues Sales () by (2012-2017)
Table Europe Oral hypoglycemic agents and insulin analogues Sales Market Share by (2012-2017)
Figure Europe Oral hypoglycemic agents and insulin analogues Sales Market Share by in 2016
Table Europe Oral hypoglycemic agents and insulin analogues Revenue (Million USD) by (2012-2017)
Table Europe Oral hypoglycemic agents and insulin analogues Revenue Market Share by (2012-2017)
Figure Europe Oral hypoglycemic agents and insulin analogues Revenue Market Share by in 2016
Table Europe Oral hypoglycemic agents and insulin analogues Price () by (2012-2017)
Table AARTI DRUGS LIMITED IN 400 022 Mumbai Company Details and Competitors
Table AARTI DRUGS LIMITED IN 400 022 Mumbai Key Oral hypoglycemic agents and insulin analogues Models and Performance
Table AARTI DRUGS LIMITED IN 400 022 Mumbai Oral hypoglycemic agents and insulin analogues Business SWOT Analysis and Forecast
Table AARTI DRUGS LIMITED IN 400 022 Mumbai Oral hypoglycemic agents and insulin analogues Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure AARTI DRUGS LIMITED IN 400 022 Mumbai Oral hypoglycemic agents and insulin analogues Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure AARTI DRUGS LIMITED IN 400 022 Mumbai Oral hypoglycemic agents and insulin analogues Sales Market Share (%) in Global (2012-2017)
Figure AARTI DRUGS LIMITED IN 400 022 Mumbai Oral hypoglycemic agents and insulin analogues Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure AARTI DRUGS LIMITED IN 400 022 Mumbai Oral hypoglycemic agents and insulin analogues Revenue Market Share (%) in Global (2012-2017)
Table Abhilash Chemicals Private Limited IN 652301 Madurai Company Details and Competitors
Table Abhilash Chemicals Private Limited IN 652301 Madurai Key Oral hypoglycemic agents and insulin analogues Models and Performance
Table Abhilash Chemicals Private Limited IN 652301 Madurai Oral hypoglycemic agents and insulin analogues Business SWOT Analysis and Forecast
Table Abhilash Chemicals Private Limited IN 652301 Madurai Oral hypoglycemic agents and insulin analogues Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure Abhilash Chemicals Private Limited IN 652301 Madurai Oral hypoglycemic agents and insulin analogues Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure Abhilash Chemicals Private Limited IN 652301 Madurai Oral hypoglycemic agents and insulin analogues Sales Market Share (%) in Global (2012-2017)
Figure Abhilash Chemicals Private Limited IN 652301 Madurai Oral hypoglycemic agents and insulin analogues Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Abhilash Chemicals Private Limited IN 652301 Madurai Oral hypoglycemic agents and insulin analogues Revenue Market Share (%) in Global (2012-2017)
Table ACTAVIS GROUP PTC EHF IS 220 Hafnarfjordur Company Details and Competitors
Table ACTAVIS GROUP PTC EHF IS 220 Hafnarfjordur Key Oral hypoglycemic agents and insulin analogues Models and Performance
Table ACTAVIS GROUP PTC EHF IS 220 Hafnarfjordur Oral hypoglycemic agents and insulin analogues Business SWOT Analysis and Forecast
Table ACTAVIS GROUP PTC EHF IS 220 Hafnarfjordur Oral hypoglycemic agents and insulin analogues Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure ACTAVIS GROUP PTC EHF IS 220 Hafnarfjordur Oral hypoglycemic agents and insulin analogues Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure ACTAVIS GROUP PTC EHF IS 220 Hafnarfjordur Oral hypoglycemic agents and insulin analogues Sales Market Share (%) in Global (2012-2017)
Figure ACTAVIS GROUP PTC EHF IS 220 Hafnarfjordur Oral hypoglycemic agents and insulin analogues Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure ACTAVIS GROUP PTC EHF IS 220 Hafnarfjordur Oral hypoglycemic agents and insulin analogues Revenue Market Share (%) in Global (2012-2017)
Table Auro Laboratories Limited IN 400030 Mumbai Company Details and Competitors
Table Auro Laboratories Limited IN 400030 Mumbai Key Oral hypoglycemic agents and insulin analogues Models and Performance
Table Auro Laboratories Limited IN 400030 Mumbai Oral hypoglycemic agents and insulin analogues Business SWOT Analysis and Forecast
Table Auro Laboratories Limited IN 400030 Mumbai Oral hypoglycemic agents and insulin analogues Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure Auro Laboratories Limited IN 400030 Mumbai Oral hypoglycemic agents and insulin analogues Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure Auro Laboratories Limited IN 400030 Mumbai Oral hypoglycemic agents and insulin analogues Sales Market Share (%) in Global (2012-2017)
Figure Auro Laboratories Limited IN 400030 Mumbai Oral hypoglycemic agents and insulin analogues Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Auro Laboratories Limited IN 400030 Mumbai Oral hypoglycemic agents and insulin analogues Revenue Market Share (%) in Global (2012-2017)
Table AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Company Details and Competitors
Table AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Key Oral hypoglycemic agents and insulin analogues Models and Performance
Table AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Oral hypoglycemic agents and insulin analogues Business SWOT Analysis and Forecast
Table AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Oral hypoglycemic agents and insulin analogues Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Oral hypoglycemic agents and insulin analogues Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Oral hypoglycemic agents and insulin analogues Sales Market Share (%) in Global (2012-2017)
Figure AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Oral hypoglycemic agents and insulin analogues Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Oral hypoglycemic agents and insulin analogues Revenue Market Share (%) in Global (2012-2017)
Table BAL PHARMA LIMITED IN 560 052 Bangalore Company Details and Competitors
Table BAL PHARMA LIMITED IN 560 052 Bangalore Key Oral hypoglycemic agents and insulin analogues Models and Performance
Table BAL PHARMA LIMITED IN 560 052 Bangalore Oral hypoglycemic agents and insulin analogues Business SWOT Analysis and Forecast
Table BAL PHARMA LIMITED IN 560 052 Bangalore Oral hypoglycemic agents and insulin analogues Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure BAL PHARMA LIMITED IN 560 052 Bangalore Oral hypoglycemic agents and insulin analogues Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure BAL PHARMA LIMITED IN 560 052 Bangalore Oral hypoglycemic agents and insulin analogues Sales Market Share (%) in Global (2012-2017)
Figure BAL PHARMA LIMITED IN 560 052 Bangalore Oral hypoglycemic agents and insulin analogues Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure BAL PHARMA LIMITED IN 560 052 Bangalore Oral hypoglycemic agents and insulin analogues Revenue Market Share (%) in Global (2012-2017)
Table BAYER AG DE 51373 Leverkusen Company Details and Competitors
Table BAYER AG DE 51373 Leverkusen Key Oral hypoglycemic agents and insulin analogues Models and Performance
Table BAYER AG DE 51373 Leverkusen Oral hypoglycemic agents and insulin analogues Business SWOT Analysis and Forecast
Table BAYER AG DE 51373 Leverkusen Oral hypoglycemic agents and insulin analogues Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure BAYER AG DE 51373 Leverkusen Oral hypoglycemic agents and insulin analogues Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure BAYER AG DE 51373 Leverkusen Oral hypoglycemic agents and insulin analogues Sales Market Share (%) in Global (2012-2017)
Figure BAYER AG DE 51373 Leverkusen Oral hypoglycemic agents and insulin analogues Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure BAYER AG DE 51373 Leverkusen Oral hypoglycemic agents and insulin analogues Revenue Market Share (%) in Global (2012-2017)
Table BIOCON LIMITED IN 560 100 Bangalore Company Details and Competitors
Table BIOCON LIMITED IN 560 100 Bangalore Key Oral hypoglycemic agents and insulin analogues Models and Performance
Table BIOCON LIMITED IN 560 100 Bangalore Oral hypoglycemic agents and insulin analogues Business SWOT Analysis and Forecast
Table BIOCON LIMITED IN 560 100 Bangalore Oral hypoglycemic agents and insulin analogues Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure BIOCON LIMITED IN 560 100 Bangalore Oral hypoglycemic agents and insulin analogues Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure BIOCON LIMITED IN 560 100 Bangalore Oral hypoglycemic agents and insulin analogues Sales Market Share (%) in Global (2012-2017)
Figure BIOCON LIMITED IN 560 100 Bangalore Oral hypoglycemic agents and insulin analogues Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure BIOCON LIMITED IN 560 100 Bangalore Oral hypoglycemic agents and insulin analogues Revenue Market Share (%) in Global (2012-2017)
Table BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Company Details and Competitors
Table BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Key Oral hypoglycemic agents and insulin analogues Models and Performance
Table BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Oral hypoglycemic agents and insulin analogues Business SWOT Analysis and Forecast
Table BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Oral hypoglycemic agents and insulin analogues Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Oral hypoglycemic agents and insulin analogues Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Oral hypoglycemic agents and insulin analogues Sales Market Share (%) in Global (2012-2017)
Figure BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Oral hypoglycemic agents and insulin analogues Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Oral hypoglycemic agents and insulin analogues Revenue Market Share (%) in Global (2012-2017)
Table Boehringer Ingelheim Pharma GmbH & Co. KG DE 55216 Ingelheim Am Rhein Company Details and Competitors
Table Boehringer Ingelheim Pharma GmbH & Co. KG DE 55216 Ingelheim Am Rhein Key Oral hypoglycemic agents and insulin analogues Models and Performance
Table Boehringer Ingelheim Pharma GmbH & Co. KG DE 55216 Ingelheim Am Rhein Oral hypoglycemic agents and insulin analogues Business SWOT Analysis and Forecast
Table Boehringer Ingelheim Pharma GmbH & Co. KG DE 55216 Ingelheim Am Rhein Oral hypoglycemic agents and insulin analogues Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2017)
Figure Boehringer Ingelheim Pharma GmbH & Co. KG DE 55216 Ingelheim Am Rhein Oral hypoglycemic agents and insulin analogues Sales (Million Unit) and Growth Rate (%) (2012-2017)
Figure Boehringer Ingelheim Pharma GmbH & Co. KG DE 55216 Ingelheim Am Rhein Oral hypoglycemic agents and insulin analogues Sales Market Share (%) in Global (2012-2017)
Figure Boehringer Ingelheim Pharma GmbH & Co. KG DE 55216 Ingelheim Am Rhein Oral hypoglycemic agents and insulin analogues Sales Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Boehringer Ingelheim Pharma GmbH & Co. KG DE 55216 Ingelheim Am Rhein Oral hypoglycemic agents and insulin analogues Revenue Market Share (%) in Global (2012-2017)
Table Chongqing Carelife Pharmaceutical Co. Ltd. CN 401 254 Chongqing Company Details and Competitors
Table CHROMO LABORATORIES INDIA PRIVATE LIMITED IN 502 307 Pashamylaram Company Details and Competitors
Table CIPLA LIMITED IN 400 013 Mumbai Company Details and Competitors
Table CKD BIO CORPORATION KR 15604 Ansan-si Company Details and Competitors
Table DISHMAN CARBOGEN AMCIS LIMITED IN 380 009 Ahmedabad Company Details and Competitors
Table DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Company Details and Competitors
Table EDMOND PHARMA S.R.L. IT 20037 Paderno Dugnano Company Details and Competitors
Table ELIXIR PHARMA IN 382 330 Ahmedabad Company Details and Competitors
Table EXEMED PHARMACEUTICALS IN 391 440 Vadodara Company Details and Competitors
Table GLENMARK PHARMACEUTICALS LIMITED IN 400 099 Mumbai Company Details and Competitors
Table GRANULES INDIA LIMITED IN 500 081 Hyderabad Company Details and Competitors
Table HARMAN FINOCHEM LIMITED IN 400 098 Mumbai Company Details and Competitors
Table Hebei Huarong Pharmaceutical Co Ltd CN 050 041 Shijiazhuang Company Details and Competitors
Table HETERO LABS LIMITED IN 500 018 Hyderabad Company Details and Competitors
Table HUADONG MEDICINE CO., LTD. CN 310 011 Hangzhou Company Details and Competitors
Table INDOCO REMEDIES LIMITED IN 400 098 Mumbai Company Details and Competitors
Table INIST ST CO., LTD. KR 369-901 Eumseong-gun Company Details and Competitors
Table IOL CHEMICALS AND PHARMACEUTICALS LTD IN 148 101 Fatehgarh Channa Village Company Details and Competitors
Table IPCA Laboratories Limited IN 400 067 Mumbai Company Details and Competitors
Table JUBILANT GENERICS LIMITED IN 571 302 Nanjangud Company Details and Competitors
Table Global Oral hypoglycemic agents and insulin analogues Sales () by Regions (2012-2017)
Table Global Oral hypoglycemic agents and insulin analogues Sales Share by Regions (2012-2017)
Figure Global Oral hypoglycemic agents and insulin analogues Sales Market Share by Regions in 2016
Figure Global Oral hypoglycemic agents and insulin analogues Sales Market Share by Regions in 2017
Table Global Oral hypoglycemic agents and insulin analogues Revenue (Million USD) by Regions (2012-2017)
Table Global Oral hypoglycemic agents and insulin analogues Revenue Market Share by Regions (2012-2017)
Figure Global Oral hypoglycemic agents and insulin analogues Revenue Market Share by Regions in 2016
Figure Global Oral hypoglycemic agents and insulin analogues Revenue Market Share by Regions in 2017
Table Global Oral hypoglycemic agents and insulin analogues Price () by Regions (2012-2017)
Table North America Oral hypoglycemic agents and insulin analogues Sales () by Regions (2012-2017)
Table North America Oral hypoglycemic agents and insulin analogues Revenue (Million USD) by Regions (2012-2017)
Figure North America Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Latin America Oral hypoglycemic agents and insulin analogues Sales () by Regions (2012-2017)
Table Latin America Oral hypoglycemic agents and insulin analogues Revenue (Million USD) by Regions (2012-2017)
Figure Latin America Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Europe Oral hypoglycemic agents and insulin analogues Sales () by Regions (2012-2017)
Table Europe Oral hypoglycemic agents and insulin analogues Revenue (Million USD) by Regions (2012-2017)
Figure Europe Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Asia & Pacific Oral hypoglycemic agents and insulin analogues Sales () by Regions (2012-2017)
Table Asia & Pacific Oral hypoglycemic agents and insulin analogues Revenue (Million USD) by Regions (2012-2017)
Figure Asia & Pacific Oral hypoglycemic agents and insulin analogues Sales () and Growth Rate (2012-2017)
Table Africa & Middle East Oral hypoglycemic agents and insulin analogues Sales () by Regions (2012-2017)
Table Africa & Middle East Oral hypoglycemic agents and insulin analogues Revenue